We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTRN
876
Pattern Group Inc
PTRN
$3.75B
$228K 0.02%
+16,670
New +$232K
RSKD icon
877
Riskified
RSKD
$712M
$228K 0.02%
48,700
+23,400
+92% +$115K
TNDM icon
878
Tandem Diabetes Care
TNDM
$1.59B
$228K 0.02%
+18,754
New +$254K
KRT icon
879
Karat Packaging
KRT
$959M
$227K 0.02%
+9,019
New +$237K
BEKE icon
880
KE Holdings
BEKE
$19.5B
$227K 0.02%
+11,965
New +$224K
EGY icon
881
Vaalco Energy
EGY
$622M
$227K 0.02%
56,470
-28,851
-34% -$111K
EEFT icon
882
Euronet Worldwide
EEFT
$2.65B
$225K 0.02%
2,566
+269
+12% +$25.8K
SCHL icon
883
CALL
Scholastic
SCHL
$807M
$225K 0.02%
+795
New +$19.7K
TCBI icon
884
Texas Capital Bancshares
TCBI
$4.32B
$224K 0.02%
2,649
-273
-9% -$23.3K
EWZS icon
885
iShares MSCI Brazil Small-Cap ETF
EWZS
$218M
$222K 0.02%
16,000
-24,000
-60% -$311K
MO icon
886
Altria Group
MO
$109B
$222K 0.02%
3,366
-9,917
-75% -$628K
PACS icon
887
PACS Group
PACS
$7.67B
$222K 0.02%
+16,181
New +$190K
KBH icon
888
KB Home
KBH
$3.47B
$222K 0.02%
+3,487
New +$211K
FHI icon
889
Federated Hermes
FHI
$4.71B
$221K 0.02%
4,263
-632
-13% -$32K
STRZ
890
Starz Entertainment Corp
STRZ
$416M
$220K 0.02%
+14,935
New +$217K
PTEN icon
891
Patterson-UTI
PTEN
$4.19B
$220K 0.02%
+42,465
New +$244K
BVN icon
892
Compañía de Minas Buenaventura
BVN
$8.78B
$219K 0.02%
9,000
-1,000
-10% -$18.7K
CMRC
893
Commerce.com Inc Series 1
CMRC
$175M
$219K 0.02%
43,852
+29,552
+207% +$142K
ATI icon
894
ATI
ATI
$31.1B
$219K 0.02%
+2,689
New +$218K
BIOA
895
BioAge Labs
BIOA
$526M
$219K 0.02%
37,193
-15,946
-30% -$74.7K
ADT icon
896
ADT
ADT
$5.49B
$218K 0.02%
25,041
-6,323
-20% -$54.2K
DNN icon
897
Denison Mines
DNN
$2.95B
$218K 0.02%
+79,132
New +$175K
NFG icon
898
National Fuel Gas
NFG
$7.78B
$217K 0.02%
+2,353
New +$205K
SO icon
899
Southern Company
SO
$105B
$217K 0.02%
+2,291
New +$214K
PII icon
900
Polaris
PII
$3.97B
$217K 0.02%
+3,733
New +$201K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.